))
A Cure to Glanzmann's Thrombasthenia on the Horizon?
Manage episode 348772232 series 3422808
Контент предоставлен Glanzmann's Research Foundation. Весь контент подкастов, включая эпизоды, графику и описания подкастов, загружается и предоставляется непосредственно компанией Glanzmann's Research Foundation или ее партнером по платформе подкастов. Если вы считаете, что кто-то использует вашу работу, защищенную авторским правом, без вашего разрешения, вы можете выполнить процедуру, описанную здесь https://ru.player.fm/legal.
Join Peter and Taylor as they speak with Dr. David Wilcox, who has spent close to 30 years researching a cure and advocating in the medical research community for Glanzmann’s.
Tune in to hear how advances in the medical field have brought him close to a cure and how you can help him get even closer.
DISCLOSURE: Dr. David A. Wilcox, Ph.D., is the inventor, President, and Founder of Platelet Targeted Therapeutics, LLC.
He has an equity interest and intellectual property rights in the company.
Dr. Wilcox is an Associate Professor of The Department of Pediatrics HEM/ONC/BMT at the Medical College of Wisconsin. The Content of this PODCAST does not necessarily represent the official views of the Medical College of Wisconsin or its sponsors.
9 эпизодов
Поделиться
